Morgan Stanley initiates coverage on Quantinuum with Equal-Weight rating

2 min read     Updated on 30 Jun 2026, 12:04 AM
scanx
Reviewed by
Radhika SScanX News Team
AI Summary

Morgan Stanley analyst Joseph Moore initiated coverage on Quantinuum with an Equal-Weight rating and a price target of $78, contrasting with Buy ratings from TD Cowen, UBS, JP Morgan, BofA Securities, and Needham. Analysts project significant long-term growth driven by the company's technological advancements and the upcoming launch of its Apollo system in 2029. The total addressable market for quantum technology is expected to surge from $1.1 billion in 2025 to $80 billion by 2035.

powered bylight_fuzz_icon
44294892

*this image is generated using AI for illustrative purposes only.

Quantinuum Inc has received a mixed reception from Wall Street as Morgan Stanley analyst Joseph Moore initiated coverage with an Equal-Weight rating and a price target of $78. This rating contrasts with recent bullish endorsements from TD Cowen, UBS, JP Morgan, BofA Securities, and Needham, which have driven a rally in the firm's shares amid federal orders supporting quantum computing research. Analysts project significant long-term growth driven by the company's technological advancements and the upcoming launch of its Apollo system.

Analyst Ratings and Price Targets

Morgan Stanley joins a roster of major firms evaluating the quantum computing company. TD Cowen analyst Krish Sankar previously initiated coverage with a Buy rating. UBS analyst David Vogt set a Buy rating with a price target of $93. JP Morgan analyst Harlan Sur assigned an Overweight rating with a price target of $97. BofA Securities analyst Vivek Arya and Needham analyst Quinn Bolton both initiated coverage with Buy ratings and price targets of $100.

Firm Analyst Rating Price Target
Morgan Stanley Joseph Moore Equal-Weight $78
TD Cowen Krish Sankar Buy N/A
UBS David Vogt Buy $93
JP Morgan Harlan Sur Overweight $97
BofA Securities Vivek Arya Buy $100
Needham Quinn Bolton Buy $100

Market Outlook and Technology

Quantinuum builds and sells quantum computers, providing the tools and access required by clients to utilize them. The company's latest platform, Helios, delivers industry-leading commercial performance and counts Amgen and BMW among its customers. Although the sector is nascent, analysts believe it is nearing a "fault-tolerant inflection." The total addressable market (TAM) for quantum technology is projected to surge from approximately $1.1 billion in 2025 to around $80 billion by 2035.

Apollo Launch and Revenue Projections

Needham highlighted Quantinuum's Quantum Charge-Coupled Device (QCCD) architecture as a key differentiator, providing a scalable path toward the fault-tolerant Apollo system. Scheduled for launch in 2029, Apollo is expected to unlock significant commercial value across pharmaceuticals, energy, materials, finance, logistics, and cryptography. The system is projected to carry an average selling price of around $500 million and support annual cloud revenue of $1 billion or more. Bolton expects revenue to grow from $31 million in 2025 to $4.3 billion in 2031, representing a compounded annual growth rate (CAGR) of approximately 128%.

Recent Stock Performance

Shares of Quantinuum declined by 3.94% to $72.59 at the time of publication on Monday. Despite the recent dip, the stock has climbed more than 19% since its IPO earlier this month.

How will the market react if the Apollo system launch is delayed beyond 2029?

What competitive threats could Quantinuum face from other quantum computing firms before Apollo's release?

Will federal funding for quantum research continue to support the sector's growth amid potential budget constraints?

like17
dislike

Craig-Hallum initiates Quantinuum coverage with Buy rating, $100 target

1 min read     Updated on 29 Jun 2026, 09:02 PM
scanx
Reviewed by
Radhika SScanX News Team
AI Summary

Craig-Hallum analyst Richard Shannon initiated coverage on Quantinuum (NASDAQ: QNT) with a Buy rating and a price target of $100. The firm joins other analysts in initiating coverage on various stocks, including Innio NV, Sunshine Silver Mining, Amdocs Ltd, and Solaris Energy Infrastructure.

powered bylight_fuzz_icon
44277067

*this image is generated using AI for illustrative purposes only.

Craig-Hallum analyst Richard Shannon initiated coverage on Quantinuum (NASDAQ: QNT) with a Buy rating and a price target of $100. This rating provides a new investment perspective for market participants, indicating a positive outlook on the company's performance and market position. Quantinuum shares closed at $75.57 on Friday.

Coverage Details

The initiation of coverage by Craig-Hallum adds to the analysis available for Quantinuum. The price target of $100 serves as a benchmark for the stock's potential valuation.

Metric Value
Rating Buy
Price Target $100
Analyst Richard Shannon
Coverage Firm Craig-Hallum

Other Analyst Initiations

Top Wall Street analysts also initiated coverage on several other names:

  • Baird analyst Ben Kallo initiated coverage on Innio NV (NASDAQ: INIO) with an Outperform rating and a price target of $50. Innio shares closed at $37.29 on Friday.
  • BMO Capital analyst Kevin O’Halloran initiated coverage on Sunshine Silver Mining And Refining Company (NYSE: SSMR) with an Outperform rating and a price target of $16.5. Sunshine Silver Mining shares closed at $13.42 on Friday.
  • Keybanc analyst Devin Au initiated coverage on Amdocs Ltd (NASDAQ: DOX) with a Sector Weight rating. Amdocs shares closed at $51.97 on Friday.
  • Needham analyst Sean Milligan initiated coverage on Solaris Energy Infrastructure Inc (NYSE: SEI) with a Buy rating and a price target of $97. Solaris Energy Infrastructure shares closed at $76.80 on Friday.

What specific catalysts does Craig-Hallum anticipate will drive Quantinuum's stock to the $100 price target?

How might this new coverage influence other analysts' ratings on Quantinuum in the near term?

What are the potential risks or challenges Quantinuum could face that could impede reaching the $100 valuation?

like15
dislike

More News on quantinuum inc